Mangalam Drugs and Organics Ltd
Mangalam Drugs and Organics Ltd Share Price Today: Live Updates & Key Insights
Get insights on Mangalam Drugs and Organics Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Mangalam Drugs and Organics Ltd Share Price Chart
MANGALAM at 10 Jul 2026 05:51 PM Pharmaceuticals
27.75 +0.49(+1.80%)
Lowest Today 27.30
Highest Today 28.59
Today's Open 27.99
Prev. Close 27.26
52 Week High 95.00
52 Week Low 22.80
Mangalam Drugs and Organics Ltd Fundamentals
Traded Volume: 39,870
Market Cap(Cr): 43.92
Avg Traded Price 27.88
1 Year return -69.69%
Upper Circuit 28.6
Lower Circuit 27.3
P/E TTM -1.00
P/B Ratio 0.418
Traded Value(Cr) 11.06
EPS TTM -28.051
Book value/Share 65.280
Dividend Yield 1Y 0.00%
Mangalam Drugs and Organics Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Mangalam Drugs and Organics Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Mangalam Drugs and Organics Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -1.77%
1M -2.05%
3M -13.20%
1Y -69.69%
YTD -5.61%
Mangalam Drugs and Organics Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Mangalam Drugs and Organics Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 36542.00
Day Before Yesterday 49779.00
1W Avg 47439.40
1M Avg 32843.90
3M Avg 24204.28
Mangalam Drugs and Organics Ltd Technical Details
Mangalam Drugs and Organics Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 27
Support 2 26
Support 3 25
Pivot Point : 27
Resistance 1 28
Resistance 2 29
Resistance 3 30
Mangalam Drugs and Organics Ltd Corporate Actions
Mangalam Drugs and Organics Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Mangalam Drugs and Organics Ltd’s capital allocation strategies.
All
Ex-Date 21-Dec-2017 Type D Description 0.50/share@5.00% Record Date 22-Dec-2017 Ratio 5.00
Dividends
Announcement Date 21-Dec-2017 Ex Dividend Date 21-Dec-2017 Dividend(%) 5
Bonus
No Bonus has been declared by MANGALAM
Splits
No Split has been declared by MANGALAM
Others
Rights No Rights has been declared by MANGALAM
Mangalam Drugs and Organics Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Mangalam Drugs and Organics Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Mangalam Drugs and Organics Ltd's relative performance and valuation against major competitors.
Stock Name Vivimed Labs Ltd ₹5.53 (+2.22%) M. Cap (Cr) 0.46 1 Yr Return (%) -79.21% P/E (TTM) -1.28 PB Ratio -0.61
Stock Name Vista Pharmaceuticals Ltd ₹7.28 (+0.69%) M. Cap (Cr) 0.45 1 Yr Return (%) -35.58% P/E (TTM) -3.72 PB Ratio 1.23
Stock Name Shelter Pharma Ltd ₹27.40 (+6.41%) M. Cap (Cr) 0.46 1 Yr Return (%) -37.16% P/E (TTM) 5.05 PB Ratio 0.63
Stock Name Mangalam Drugs and Organics Ltd ₹27.75 (+1.80%) M. Cap (Cr) 0.44 1 Yr Return (%) -69.69% P/E (TTM) -0.99 PB Ratio 0.43
Stock Name ANG Lifesciences India Ltd ₹33.25 (-4.56%) M. Cap (Cr) 0.43 1 Yr Return (%) -1.95% P/E (TTM) -3.96 PB Ratio 0.83
Stock Name Rajnish Wellness Ltd ₹0.41 (0.00%) M. Cap (Cr) 0.42 1 Yr Return (%) -55.43% P/E (TTM) -7.81 PB Ratio 0.41
Stock Name Sandu Pharmaceuticals Ltd ₹41.00 (+1.06%) M. Cap (Cr) 0.40 1 Yr Return (%) -18.57% P/E (TTM) 16.32 PB Ratio 0.91
Mangalam Drugs and Organics Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Mangalam Drugs and Organics Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 4.16 Mar 2025 42.76 Mar 2024 12.17 Mar 2023 39.52 Mar 2022 25.71
PARTICULARS Investing Activities Mar 2026 -11.72 Mar 2025 -19.47 Mar 2024 -17.90 Mar 2023 -22.17 Mar 2022 -27.33
PARTICULARS Financing Activities Mar 2026 5.66 Mar 2025 -21.71 Mar 2024 5.70 Mar 2023 -16.62 Mar 2022 2.98
PARTICULARS Net Cash Flow Mar 2026 -1.90 Mar 2025 1.57 Mar 2024 -0.04 Mar 2023 0.73 Mar 2022 1.36
Mangalam Drugs and Organics Ltd Shareholding Pattern
This shows the ownership breakdown of Mangalam Drugs and Organics Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 35.65%
Public 64.03%
Other Institutions 0.0%
FII 0.32%
Mutual Funds N/A%
About Mangalam Drugs and Organics Ltd
Mangalam Drugs and Organics Limited was initially incorporated as 'Advent Pharma Private Limited' on April 18, 1972. On July 1, 1997, the Company changed the name from Advent Pharma Private Limited to Mangalam Drugs and Organics Private Limited. Thereafter, it converted the status into a Public Limited Company, changing the name to Mangalam Drugs and Organics Limited on August 10, 2001. The company was established to set up a plant for manufacture of organic and inorganic chemicals.The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 2004-05, the capacity is being further enhanced to 960 MTPA. During the year 2005-06, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.During the year 2007-08, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline & Allied Products from 250 tons to 350 tons.During the year 2009-10, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHO-Geneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.During the year 2017-18, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100); Tenofovir Disoproxil Fumarate (APIMF204); Artemether (APIMF138); Emtricitabine (WHO API314); Efavirenz (WHO API 318).In late 2024, the company has expanded its anti-malaria API portfolio with the introduction of Pyronaridine.
Chairman / Executive Director / Managing Director
Govardhan M Dhoot
Registered office 3rd Floor Rupam Building, 239 P D Mello Road, Mumbai, Maharashtra, 400001
FAX :91-22-22616200/6300/8787
Background
Incorporation Year 1972
Face Value ₹10.00
Market Lot 1
FAQs on Mangalam Drugs and Organics Ltd
How to buy Mangalam Drugs and Organics Ltd shares?
To buy Mangalam Drugs and Organics Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Mangalam Drugs and Organics Ltd?
The company has a market capitalization of ₹43.92.
What is the PE & PB ratio of Mangalam Drugs and Organics Ltd?
PE is -1 and PB is 0.418.
What is the Mangalam Drugs and Organics Ltd dividend for 2025–26?
For the 2025–26 financial year, Mangalam Drugs and Organics Ltd declared a final dividend of 0.00% per share.